Cite
HARVARD Citation
Pak, E. et al. (2019). A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. Neuro-oncology. 21 (9), pp. 1150-1163. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Pak, E. et al. (2019). A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma. Neuro-oncology. 21 (9), pp. 1150-1163. [Online].